Lessons Learned About Antibodies

The term “antibody” has entered our main-stream vocabulary due to the advent of SARS-CoV-2 with manifestation of disease as COVID-19.

Antibodies are also called immunoglobulins. They are protein/carbohydrate structures of five different classes produced in defensive response to a foreign invader. Each class binds to alien structures responsible for inducing a host reaction.

The basic unit for each antibody class incorporates a constant portion, a structural part that does not change, and another region that is variable. This variable region enables antibodies’ abilities to recognize and attach to various foreign invaders, or antigens. Over a lifetime, each human encounters many types of antigens ranging from allergens, to toxins, to various microorganisms including viruses.

Humans produce white blood cells called B-cells, which mature into plasma cells that produce five classes of immunoglobulins. Antibodies may interfere with infection through virus specific methods of neutralization. Examples include blocking virus attachment to the host cell, preventing viruses from entering the cell, clumping of multiple virus particles, disrupting reformation of virus particles, and others.

Antibodies are grouped into two primary types, termed monoclonal or polyclonal, thusly differentiated by methods through which they are produced. Polyclonal antibodies are generated in living animals from multiple B-cells thus the antibodies are heterogeneous in nature. They identify and react to various sites or epitopes on the antigens. 

Conversely, monoclonal antibodies are created artificially and propagated in tissue culture systems.  They are derived from identical B-cells called clones, which originated from a single parent cell. Therefore, monoclonal antibodies possess an ability to recognize the same epitope on an antigen and specifically bind to that one site.

The process to produce monoclonal antibodies starts with an injection of the desired antigen into a test-subject (usually a mouse), with repeated antigen injections, encouraging an immune reaction. Once the animal develops a response to the antigen, B-cells are isolated from the test subject’s spleen and fused with myeloma cells, creating immortalized B-cell-myeloma hybridomas.

These hybridoma cells possess the ability to grow continuously in tissue culture while producing antibodies. Next, the cells in culture are screened for production of the desired monoclonal antibody, which binds with the antigen of interest in the desired region. Positive characteristics for monoclonal antibodies include their high specificity for a single epitope which results in low cross-reactivity, and commercial production of large quantities resulting in highly homogeneous products.

Drawbacks for monoclonal antibody generation include a lengthy time frame for production, and high cost associated with their development.

Regeneron developed two monoclonal antibodies; each one attaches to a different epitope of the receptor binding domain of the SARS-CoV-2 spike protein. The virus spike protein confers binding ability with subsequent integration into host cells via the ACE2 receptor.

In phase II/III testing, a cocktail of the two monoclonals seems to neutralize the virus’s ability to bind, thus decreasing infection. In addition, the monoclonals do not seem to impair normal enzyme binding with resultant cell function for the ACE2 receptor. It is hoped this monoclonal cocktail may prove useful for people with COVID-19 and as prophylactic treatment for SARS-CoV-2 infection.

Programming Note:

Listen to Julia Brodt report this story live during Talk Ten Tuesdays today at 10 a.m. EST.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

Related Stories

Understanding the Wright Approach

Understanding the Wright Approach

Concern about hospitals sharing space has caused angst for several years. But as reiterated by Centers for Medicare & Medicaid Services (CMS) official David Wright,

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Frank Cohen shows you how to leverage the Comprehensive Error Rate Testing Program (CERT) to create your own internal coding and billing risk assessment plan, including granular identification of risk areas and prioritizing audit tasks and functions resulting in decreased claim submission errors, reduced risk of audit-related damages, and a smoother, more efficient reimbursement process from Medicare.

April 9, 2024
2024 Observation Services Billing: How to Get It Right

2024 Observation Services Billing: How to Get It Right

Dr. Ronald Hirsch presents an essential “A to Z” review of Observation, including proper use for Medicare, Medicare Advantage, and commercial payers. He addresses the correct use of Observation in medical patients and surgical patients, and how to deal with the billing of unnecessary Observation services, professional fee billing, and more.

March 21, 2024
Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Explore the top-10 federal audit targets for 2024 in our webcast, “Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets,” featuring Certified Compliance Officer Michael G. Calahan, PA, MBA. Gain insights and best practices to proactively address risks, enhance compliance, and ensure financial well-being for your healthcare facility or practice. Join us for a comprehensive guide to successfully navigating the federal audit landscape.

February 22, 2024
Mastering Healthcare Refunds: Navigating Compliance with Confidence

Mastering Healthcare Refunds: Navigating Compliance with Confidence

Join healthcare attorney David Glaser, as he debunks refund myths, clarifies compliance essentials, and empowers healthcare professionals to safeguard facility finances. Uncover the secrets behind when to refund and why it matters. Don’t miss this crucial insight into strategic refund management.

February 29, 2024
2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

HIM coding expert, Kay Piper, RHIA, CDIP, CCS, reviews the guidance and updates coders and CDIs on important information in each of the AHA’s 2024 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 15, 2024

Trending News

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →